Señales en vivo de RLMD | Maximiza tus Ganancias con Getagraph.com

COMPRAR 118418 min ago

@ $5.51

Emitido: 14 feb 2024 @ 15:13

Retorno: -30.13%

Señal anterior: feb 14 - 09:30

Señal anterior: Vender

Retorno: 2.99 %

Live Chart Being Loaded With Signals

Commentary (6 may 2024 @ 16:00):

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders...

Stats
Volumen de hoy	81 945.00
Volumen promedio	183 121
Capitalización de mercado	116.17M
EPS	$0 ( 2024-03-19 )
Próxima fecha de ganancias	( $-0.900 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.170
ATR14	$0.0170 (0.44%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-31	Traversa Sergio	Buy	27 460	Common Stock
2024-01-30	Traversa Sergio	Buy	40 999	Common Stock
2024-01-29	Traversa Sergio	Buy	31 541	Common Stock
2024-01-31	Shenouda Maged	Buy	6 875	Common Stock
2024-01-30	Shenouda Maged	Buy	15 000	Common Stock

INSIDER POWER
66.71
Last 97 transactions
Buy: 7 635 369 \| Sell: 1 906 109

Volumen Correlación

Largo: 0.06 (neutral)

Corto: -0.68 (moderate negative)

Signal:(29.886) Neutral

Relmada Therapeutics Inc Correlación

10 Correlaciones Más Positivas
TCRT	0.953
WISA	0.929
TTCF	0.925
MDVL	0.919
PCVX	0.917
VSTA	0.915
QTEK	0.914
VIRX	0.914
FNCH	0.913
AVO	0.912

10 Correlaciones Más Negativas
SLGN	-0.904
STAY	-0.904
MGI	-0.903
WEN	-0.903
CCRC	-0.903
IBEX	-0.9
IMMR	-0.899
ISIG	-0.898
MNKD	-0.88
NTUS	-0.878

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Relmada Therapeutics Inc Correlación - Moneda/Commodity

-0.67
( moderate negative )

-0.42
( neutral )

0.00
( neutral )

-0.60
( weak negative )

0.42
( neutral )

0.48
( neutral )

Relmada Therapeutics Inc Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-3.28

FY	2023
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-3.28

FY	2022
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-5.30

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-8.06

Financial Reports:

No articles found.

Relmada Therapeutics Inc

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.

Actualizaciones en tiempo real para Relmada Therapeutics Inc [RLMD]

Upcoming Earnings Alert